Evidence map›Paper›PMID 36636818›Full record

ArticleEMBO molecular medicine2023

Interferon regulates neural stem cell function at all ages by orchestrating mTOR and cell cycle.

Damian Carvajal Ibañez, Maxim Skabkin, Jooa Hooli, Santiago Cerrizuela, Manuel Göpferich, Adrien Jolly, Katrin Volk, Marc Zumwinkel, Matilde Bertolini, Gianluca Figlia and 6 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Frontiers in cellular neuroscience · 2023
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Damian Carvajal Ibañez *Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0001-7298-3139
Maxim Skabkin *Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jooa Hooli *Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-8026-9020
Santiago CerrizuelaDivision of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-6734-0398
Manuel GöpferichDivision of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Adrien JollyDivision of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-2609-5621
Katrin VolkDivision of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marc ZumwinkelDivision of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Matilde BertoliniCenter for Molecular Biology of Heidelberg University (ZMBH) & German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany.
Gianluca FigliaFaculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Thomas HöferDivision of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guenter KramerCenter for Molecular Biology of Heidelberg University (ZMBH) & German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany.ORCID 0000-0001-7552-8393
Simon AndersBioquant, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-4868-1805
Aurelio A TelemanDivision of Signal Transduction in Cancer and Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-4237-9368
Anna Marciniak-CzochraInstitute of Applied Mathematics, Heidelberg University, Heidelberg, Germany.
Ana Martin-VillalbaDivision of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-9405-8910

Funding

Deutsche Forschungsgemeinschaft (DFG) SFB873Deutsches Krebsforschungszentrum (DKFZ)EC ¦ ERC ¦ HORIZON EUROPE European Research Council (ERC)Helmholtz Association () ZT-0026Klaus Tschira Stiftung (KTS)
6 · The paper itself

Abstract

Stem cells show intrinsic interferon signalling, which protects them from viral infections at all ages. In the ageing brain, interferon signalling also reduces the ability of stem cells to activate. Whether these functions are linked and at what time interferons start taking on a role in stem cell functioning is unknown. Additionally, the molecular link between interferons and activation in neural stem cells and how this relates to progenitor production is not well understood. Here we combine single-cell transcriptomics, RiboSeq and mathematical models of interferon to show that this pathway is important for proper stem cell function at all ages in mice. Interferon orchestrates cell cycle and mTOR activity to post-transcriptionally repress Sox2 and induces quiescence. The interferon response then decreases in the subsequent maturation states. Mathematical simulations indicate that this regulation is beneficial for the young and harmful for the old brain. Our study establishes molecular mechanisms of interferon in stem cells and interferons as genuine regulators of stem cell homeostasis and a potential therapeutic target to repair the ageing brain.

Indexed as

InterferonsNeural Stem CellsAnimalsBrainCell CycleMiceTOR Serine-Threonine KinasesInterferonsTOR Serine-Threonine KinasesageingdormancyinterferonmTORstem cells

Identifiers

PMID36636818
PMCPMC10086582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.